Bruce Imbert

With over 20 years' experience in healthcare, I bridge the gap between cutting-edge CNS research and accessible care. I have successfully led clinical trials (Phase I-III), from conception to commercialization, for groundbreaking drugs and digital therapies in the fields of addiction and psychiatry.

As a collaborative leader, I forge partnerships with academic institutions, government agencies and industry leaders to unleash the power of collective innovation. My strong relationships with investors enable me to secure the capital needed for organizational growth and research.

Adaptable and resourceful, my diverse background and cultural exposure give me a unique perspective on challenges. I'm constantly learning and translating scientific breakthroughs into tangible improvements for patients and professionals.

My areas of expertise: Addiction and psychiatry, CNS therapeutics, pharmaceutical and digital development, SaMD, life sciences innovation, regulatory strategy, early and late-stage clinical development, translational medicine, clinical pharmacology, life cycle management, real-world evidence, medical education.With over 20 years' experience in healthcare, I bridge the gap between cutting-edge CNS research and accessible care. I have successfully led clinical trials (Phase I-III), from conception to commercialization, for groundbreaking drugs and digital therapies in the fields of addiction and psychiatry. As a collaborative leader, I forge partnerships with academic institutions, government agencies and industry leaders to unleash the power of collective innovation. My strong relationships with investors enable me to secure the capital needed for organizational growth and research. Adaptable and resourceful, my diverse background and cultural exposure give me a unique perspective on challenges. I'm constantly learning and translating scientific breakthroughs into tangible improvements for patients and professionals. My areas of expertise: Addiction and psychiatry, CNS therapeutics, pharmaceutical and digital development, SaMD, life sciences innovation, regulatory strategy, early and late-stage clinical development, translational medicine, clinical pharmacology, life cycle management, real-world evidence, medical education.